info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Esomar23 wcrc
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Intracranial Aneurysm Market Research Report By Type (Saccular Aneurysms, Fusiform Aneurysms, Dissecting Aneurysms, Mycotic Aneurysms), By Diagnosis Method (Computed Tomography, Magnetic Resonance Imaging, Digital Subtraction Angiography, Ultrasound), By Treatment Method (Surgical Clipping, Endovascular Coiling, Flow Diverters, Stenting), By End User (Hospitals, Neurology Clinics, Emergency Care Facilities, Research Institutions) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035


ID: MRFR/HC/40121-HCR | 200 Pages | Author: Garvit Vyas| January 2025

Intracranial Aneurysm Market Overview


As per MRFR analysis, the Intracranial Aneurysm Market Size was estimated at 4.06 (USD Billion) in 2023. The Intracranial Aneurysm Market Industry is expected to grow from 4.18(USD Billion) in 2024 to 5.8 (USD Billion) by 2035. The Intracranial Aneurysm Market CAGR (growth rate) is expected to be around 3.03% during the forecast period (2025 - 2035).


Key Intracranial Aneurysm Market Trends Highlighted


The expansion of the global intracranial aneurysm market is chiefly due to the increased incidence of aging population and cerebrovascular diseases. Advancements in medical devices such as enhanced imaging modalities and minimally invasive procedures are making diagnosis and treatment better. Moreover, growing knowledge about the disease and encouraging more people to visit the physician therefore expanding the market. There is an increase in the use of advanced medical devices, including surgical clips and endovascular coiling systems, indicating a change in treatment methods and it, in turn, drives the market.


The Global Intracranial Aneurysm Market has several chances especially in developing countries where the demand for the growing healthcare needs is emerging. The augmented need of efficient treatment solutions gives established and newly formed companies a new market. Established firms may also be able to take advantage of this by designing new sophisticated instruments and technologies that will optimize the patient outcome. New instruments and technologies can be developed through collaborations and partnerships between hospitals, research institutions and healthcare providers in order to address the new emerging needs of the patient. Also. The global intracranial aneurysm market has several opportunities including a growing awareness of the disease which increases patient referral.


Recent trends indicate a growing preference for less invasive treatment options, making endovascular techniques a preferred choice among healthcare providers. This trend reflects a fundamental shift in how intracranial aneurysms are managed. Investment in research and development is also rising, leading to the introduction of novel therapies, and improved surgical techniques. The increasing role of telemedicine in patient follow-up and monitoring signifies a modernization of patient care and convenience. Furthermore, the integration of artificial intelligence into diagnostic processes is expected to enhance predictive analytics and treatment planning, marking an exciting phase for the market.


Intracranial Aneurysm Market size


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Intracranial Aneurysm Market Drivers


Increasing Prevalence of Intracranial Aneurysms


The Global Intracranial Aneurysm Market Industry is primarily driven by the rising incidence of intracranial aneurysms. With aging populations and increasing susceptibility to various health conditions, including hypertension and smoking, the rate of diagnosed aneurysms is on the rise. This growing prevalence necessitates more effective treatment options and medical interventions, thereby boosting market demand. Furthermore, advancements in imaging techniques, such as MRI and CT scans, have led to earlier and more accurate diagnosis of intracranial aneurysms.As healthcare providers become more adept at identifying these conditions, more patients are being treated, which further propels the market forward. Training and educating healthcare professionals regarding the risks associated with unrecognized aneurysms can also lead to proactive diagnostics and interventions. This trend is expected to continue, contributing significantly to market growth in the coming years. As more patients seek assistance and treatment options, including surgical and endovascular procedures, the Global Intracranial Aneurysm Market Industry will see substantial growth opportunities.Comprehensive patient management and post-treatment therapies may also enhance patient survival rates, leading to further development and investments in this sector.


Technological Advancements in Treatment Modalities


Rapid advancements in technology related to the treatment of intracranial aneurysms have significantly impacted the Global Intracranial Aneurysm Market Industry. Innovations in minimally invasive techniques, such as endovascular coiling and flow diversion, have transformed how aneurysms are treated. These techniques not only enhance the safety of the procedures but also reduce recovery times and hospital stays for patients. The development of advanced imaging technologies, including 3D angiography and intraoperative imaging, allows surgeons to visualize the aneurysm more clearly, leading to better outcomes and improved patient management.As more healthcare facilities adopt these advanced technologies, the overall efficiency and success rates of treatments are expected to increase, driving market growth.


Rising Healthcare Expenditure


The increase in global healthcare expenditure is another key driver for the Global Intracranial Aneurysm Market Industry. More countries are focusing on enhancing their healthcare systems, improving access to advanced treatments for conditions like intracranial aneurysms. With increased funding, hospitals and healthcare providers can invest in state-of-the-art medical equipment and facilities that specialize in the diagnosis and treatment of aneurysms.Furthermore, as governments and private insurers expand coverage and reimbursement policies for newer and more effective treatments, more patients are able to access care, ultimately contributing to the growth of the market.


Intracranial Aneurysm Market Segment Insights


Intracranial Aneurysm Market Type Insights


The Global Intracranial Aneurysm Market revenue reflects significant growth within the Type segment, driven by an increasing awareness of brain health and advances in medical technologies. For 2024, the Saccular Aneurysms segment holds the majority share of the market, valued at 2.2 USD Billion, representing a prominent focus on this type due to its prevalence and clinical impact. The Fusiform Aneurysms segment follows, valued at 1.1 USD Billion, showcasing its relevance in the Global Intracranial Aneurysm Market segmentation as it is typically associated with a wide range of vascular pathologies, thus increasing the need for targeted treatments. Dissecting Aneurysms, valued at 0.7 USD Billion in 2024, also plays a critical role in the market, as they often present acute complications leading to higher clinical urgency and intervention needs. 


Moreover, Mycotic Aneurysms, while relatively smaller in market valuation at 0.18 USD Billion for 2024, are significant due to their potential association with systemic infections, highlighting a specialized area of treatment within the Global Intracranial Aneurysm Market industry. With the expected growth trajectory in these segments, the market is positioned for a valuable evolution as healthcare providers continue to invest in innovative surgical and endovascular techniques. The increasing awareness of the impact of these aneurysms on patient health is a key driver for market expansion. Factors like aging populations, genetic predispositions, and lifestyle-related health issues contribute to the rising prevalence of these conditions. Additionally, the Global Intracranial Aneurysm Market data suggests that advancements in diagnostic imaging are enhancing the detection rates, leading to more timely interventions. 


Furthermore, the increasing implementation of minimally invasive surgical techniques is likely to promote the growth of the Saccular and Fusiform Aneurysms segments, which dominate treatment frameworks due to their recognized benefits in reducing recovery times and improving patient outcomes. The market dynamics underscore the necessity for ongoing research and development aimed at improving treatment options for all types of intracranial aneurysms, thereby presenting significant opportunities for growth, especially in the segments characterized by acute care needs, like Dissecting Aneurysms. Overall, the refining of the Global Intracranial Aneurysm Market Statistics showcases a landscape ripe for innovation while addressing key challenges like treatment accessibility and awareness across diverse population demographics.


Intracranial Aneurysm Market Segment


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Intracranial Aneurysm Market Diagnosis Method Insights


The Global Intracranial Aneurysm Market for Diagnosis Method is gaining momentum as advancements in imaging technology continue to evolve. By 2024, the market is expected to be valued at approximately 4.18 billion USD, highlighting its growing significance in the healthcare industry. The segmentation of this market includes various imaging techniques such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Digital Subtraction Angiography, and Ultrasound, each contributing uniquely to diagnosis procedures. Among these, Digital Subtraction Angiography plays a crucial role, offering detailed vascular images that facilitate accurate assessments of aneurysms, thus driving its significance in clinical practices.


Meanwhile, Magnetic Resonance Imaging is known for its non-invasive nature, making it a favored choice among patients and healthcare providers alike. Ultrasound, being a real-time imaging technique, supports bedside evaluations, increasing its utility in emergency settings. Overall, the increasing prevalence of vascular diseases, along with technology upgrades, leads to notable growth within the Global Intracranial Aneurysm Market revenue and enhances diagnostic accuracy within the medical field. The Global Intracranial Aneurysm Market data shows considerable opportunities for innovation, along with challenges such as the need for trained professionals to interpret complex imaging results effectively.


Intracranial Aneurysm Market Treatment Method Insights


The Global Intracranial Aneurysm Market encompasses various treatment methods, with a projected value of 4.18 billion USD in 2024. Treatment methodologies are crucial in addressing intracranial aneurysms, aimed at reducing the risk of rupture and associated complications. Among these methods, Surgical Clipping has historically been a common approach, favored for its effectiveness in securing aneurysms. In contrast, Endovascular Coiling is becoming increasingly preferred due to its minimally invasive nature, allowing for shorter recovery times and less trauma to patients.Flow Diverters have emerged as a significant innovation, especially for complex aneurysms, as they promote blood flow rerouting, effectively reducing pressure on the aneurysm. 


Stenting also plays a vital role, often used in conjunction with other techniques to reinforce the vessel wall and prevent re-rupturing of treated areas. The combined popularity of these treatment approaches reflects ongoing advancements and offers a glimpse into future growth trajectories for the Global Intracranial Aneurysm Market, ultimately contributing to improved patient outcomes and increased market dynamics.As the Global Intracranial Aneurysm Market continues to evolve, the integration of cutting-edge technologies will likely shape treatment methodologies and their implications within the industry.


Intracranial Aneurysm Market End User Insights


The Global Intracranial Aneurysm Market revenue is expected to reach 4.18 billion USD by 2024, reflecting the pivotal role of various End Users in the healthcare ecosystem addressing this critical condition. Hospitals are significant players in this market, primarily due to their comprehensive resources for diagnosis and treatment. Neurology clinics attract patients seeking specialized care, thus becoming essential in managing intracranial aneurysms. Emergency care facilities serve as the first point of contact during acute cases, making their contribution vital for timely interventions.Furthermore, research institutions drive innovation and treatment advancements, supporting the overall market growth by exploring new therapies and technologies. 


The combination of these End Users highlights both growth opportunities and challenges, as they navigate increasing patient loads and the need for improved diagnostic tools and treatment options within the Global Intracranial Aneurysm Market industry. With increasing awareness and advancements in medical practices, this market segment is anticipated to grow steadily in future years, supported by various factors that drive demand across all mentioned areas.


Intracranial Aneurysm Market Regional Insights


The Global Intracranial Aneurysm Market has shown a diverse regional distribution, contributing significantly to its overall revenue. In 2024, North America leads the market with a valuation of 1.78 USD Billion and is projected to reach 2.5 USD Billion by 2035, showcasing its dominant position due to advanced healthcare infrastructure and higher awareness levels regarding neurological conditions. Europe follows with a valuation of 1.3 USD Billion in 2024, expected to grow to 1.9 USD Billion, fueled by robust healthcare systems and increasing research initiatives.


The APAC region, valued at 0.8 USD Billion in 2024 and projected to reach 1.1 USD Billion, is emerging as a significant player owing to rising healthcare expenditures and a growing population at risk of aneurysms. South America and MEA are the smallest segments, each starting at 0.15 USD Billion in 2024, with both expected to grow to 0.25 USD Billion by 2035, reflecting challenges such as less developed healthcare facilities and lower awareness, yet presenting opportunities for growth through healthcare improvements. Each regional sector's growth is influenced by factors such as technological advancements, demographic trends, and the increasing prevalence of intracranial aneurysms, making the Global Intracranial Aneurysm Market segmentation crucial for understanding market dynamics and strategic planning.


Intracranial Aneurysm Market Region


Source: Primary Research, Secondary Research, MRFR Database and Analyst Review


Intracranial Aneurysm Market Key Players and Competitive Insights


The Global Intracranial Aneurysm Market is characterized by a dynamic competitive landscape where companies are consistently striving for innovation, strategic collaborations and enhanced market reach. With the increasing prevalence of neurological disorders and a greater awareness around early detection and intervention, companies are focusing on developing advanced treatment options that cater to the diverse needs of patients globally. This market also increasingly relies on technological advancements, with many players investing heavily in research and development to create less invasive and highly effective solutions. The competitive tactics employed by various stakeholders include mergers and acquisitions, partnerships with healthcare providers, and the expansion of product portfolios.


As a result, understanding the competitive dynamics is crucial for stakeholders looking to navigate this rapidly evolving market successfully.Abbott Laboratories holds a significant position within the Global Intracranial Aneurysm Market, leveraging its extensive research capabilities and innovative product pipeline. The company is known for its commitment to advancing healthcare and developing cutting-edge technologies that specifically target intricate neurological procedures, including those involving intracranial aneurysms. Abbott Laboratories has established itself with its comprehensive suite of treatment options that enhance both efficacy and safety profiles in aneurysm management. 


The company benefits from a robust distribution network that enables it to maintain a strong market presence and provide access to its innovative solutions worldwide. The alignment of Abbott Laboratories’ strategic initiatives with ongoing developments in the field of neurovascular intervention further solidifies its influence in the market.MicroVention is another key player in the Global Intracranial Aneurysm Market, recognized for its specialized focus on innovative neurovascular products and technologies. The company has effectively carved a niche for itself by concentrating on minimally invasive solutions and catheters designed for the treatment of intracranial aneurysms and related conditions. 


MicroVention’s strength lies in its commitment to research and development, allowing it to consistently introduce groundbreaking products that meet the evolving needs of healthcare practitioners and patients alike. The company's reputation for quality and reliability is well-recognized among neurosurgeons and interventionalists, leading to strong brand loyalty. Moreover, MicroVention's strategic partnerships and collaborations further enhance its competitive standing, as it actively engages in initiatives aimed at improving overall patient outcomes in the neurovascular realm.


Key Companies in the Intracranial Aneurysm Market Include



  • Abbott Laboratories

  • MicroVention

  • Merit Medical Systems

  • Cogentix Medical

  • Kimal S.A.

  • Terumo

  • Penumbra

  • Asahi Intecc

  • NeuroVasc Technologies

  • Stryker

  • Bayer AG

  • Boston Scientific

  • Medtronic

  • Nicolet Biomedical

  • Johnson and Johnson


Intracranial Aneurysm Market Industry Developments


The Global Intracranial Aneurysm Market has recently seen significant developments, particularly among key players such as Abbott Laboratories, Boston Scientific, and Medtronic. The increasing incidence of intracranial aneurysms and advancements in diagnostic techniques are driving market growth. Companies like MicroVention and Stryker are expanding their product portfolios with innovative solutions such as embolization devices and flow diversion systems. There has been heightened interest in strategic collaborations, with reports of alliances formed to enhance R&D capabilities and strengthen the market’s presence. Notably, Merger and Acquisition activities are prevalent, with some companies pursuing acquisitions to integrate advanced technologies and improve clinical outcomes; however, specific recent mergers have not been widely publicized. The market valuation of leading firms is climbing, influenced by factors such as technological advancements and growing healthcare expenditure, which simultaneously propels investment in the field. Firms like Terumo and Penumbra are also responding to varying market needs, enhancing their offerings to include minimally invasive treatments. The combined efforts to innovate and collaborate are reshaping the competitive landscape of the Global Intracranial Aneurysm Market, signaling robust growth potential ahead.


Intracranial Aneurysm Market Segmentation Insights


Intracranial Aneurysm MarketTypeOutlook



  • Saccular Aneurysms

  • Fusiform Aneurysms

  • Dissecting Aneurysms

  • Mycotic Aneurysms


Intracranial Aneurysm MarketDiagnosis MethodOutlook



Intracranial Aneurysm MarketTreatment MethodOutlook



  • Surgical Clipping

  • Endovascular Coiling

  • Flow Diverters

  • Stenting


Intracranial Aneurysm MarketEnd UserOutlook



  • Hospitals

  • Neurology Clinics

  • Emergency Care Facilities

  • Research Institutions


Intracranial Aneurysm MarketRegionalOutlook



  • North America

  • Europe

  • South America

  • Asia Pacific

  • Middle East and Africa


 

Report Attribute/Metric Source: Details
MARKET SIZE 2023 4.06(USD Billion)
MARKET SIZE 2024 4.18(USD Billion)
MARKET SIZE 2035 5.8(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 3.03% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
MARKET FORECAST PERIOD 2025 - 2035
HISTORICAL DATA 2019 - 2024
MARKET FORECAST UNITS USD Billion
KEY COMPANIES PROFILED Abbott Laboratories, MicroVention, Merit Medical Systems, Cogentix Medical, Kimal S.A., Terumo, Penumbra, Asahi Intecc, NeuroVasc Technologies, Stryker, Bayer AG, Boston Scientific, Medtronic, Nicolet Biomedical, Johnson and Johnson
SEGMENTS COVERED Type, Diagnosis Method, Treatment Method, End User, Regional
KEY MARKET OPPORTUNITIES Rising aging population prevalence, Advancements in surgical techniques, Increased awareness and screening, Growth in minimally invasive procedures, Emerging markets demand expansion.
KEY MARKET DYNAMICS Increasing prevalence of aneurysms, Advancements in treatment technologies, Growing awareness and diagnosis, Rise in aging population, Expansion of healthcare facilities
COUNTRIES COVERED North America, Europe, APAC, South America, MEA


Frequently Asked Questions (FAQ) :

The Global Intracranial Aneurysm Market is expected to be valued at 4.18 USD Billion in 2024.

By 2035, the Global Intracranial Aneurysm Market is projected to reach a value of 5.8 USD Billion.

The expected CAGR for the Global Intracranial Aneurysm Market from 2025 to 2035 is 3.03%.

In 2024, North America is expected to hold the largest market share, valued at 1.78 USD Billion.

The market for Saccular Aneurysms is projected to be valued at 2.2 USD Billion in 2024.

Key players in the market include Abbott Laboratories, MicroVention, and Medtronic, among others.

The Fusiform Aneurysms segment is expected to be valued at 1.5 USD Billion in 2035.

The market for Dissecting Aneurysms is projected to grow to 1.1 USD Billion by 2035.

North America is anticipated to reach 2.5 USD Billion, while Europe may reach 1.9 USD Billion in 2035.

The market for Mycotic Aneurysms is expected to be valued at 0.18 USD Billion in 2024.

Leading companies partner with us for data-driven Insights.

clients

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.